Literature DB >> 11307030

The influence of CpG motifs on a protein or DNA-based Th2-type immune response against major pollen allergens Bet v 1a, Phl p 2 and Escherichia coli-derived beta-galactosidase.

R Hochreiter1, A Hartl, J Freund, R Valenta, F Ferreira, J Thalhamer.   

Abstract

BACKGROUND: DNA immunization and protein immunization with CpG motifs as adjuvants represent promising approaches in allergen-specific immunotherapy.
OBJECTIVE: We investigated the effect of coinjection or prepriming with CpG-ODN on Th2-type responses induced by gene gun and protein immunization.
METHODS: BALB/c mice were immunized with the gene gun using plasmid DNA containing the cDNAs coding for the genes of Bet v 1a, Phl p 2 and beta-galactosidase or with the purified Al(OH)(3)-adsorbed proteins. In addition, CpG-ODN were applied by coinjection or by prepriming treatment. Antibody and cytokine responses were measured by ELISA, proliferative and cytotoxic responses were determined by standard labeling procedures. Furthermore, the allergenic activity of sera was measured by passive cutaneous anaphylaxis.
RESULTS: Gene gun immunization and protein immunization induced a clear Th2-type response for all antigens. The Th1-promoting effect of CpG-ODN coinjection together with gene gun immunization was restricted to beta-galactosidase as indicated by the increase of IgG2a and a marked expression of IFN-gamma. CpG motifs also increased the specific cytotoxic response against beta-galactosidase. Prepriming with CpG-ODN and gene gun or protein immunization with Bet v 1a exhibited no significant difference to the non-CpG control group. However, sera from mice preprimed with CpG-ODN induced no anaphylaxis with gene gun immunization, but with protein immunization.
CONCLUSIONS: The effect of CpG motifs in vivo depends on a variety of parameters like the nature of the antigen and the immunization modality. Furthermore, our studies indicate that a combination of CpG + DNA immunization may be more effective in antagonizing Th2 responses than the combination of CpG + protein immunization. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11307030     DOI: 10.1159/000053772

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  6 in total

1.  IgE-mediated allergen gene vaccine platform targeting human antigen-presenting cells through the high-affinity IgE receptor.

Authors:  Anne Behnecke; Wei Li; Ling Chen; Andrew Saxon; Ke Zhang
Journal:  J Allergy Clin Immunol       Date:  2009-05-07       Impact factor: 10.793

2.  CpG motif acts as a 'danger signal' and provides a T helper type 1-biased microenvironment for DNA vaccination.

Authors:  Ling Liu; Xiaohui Zhou; Hua Liu; Li Xiang; Zhenghong Yuan
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

3.  Adjuvant activity of the catalytic A1 domain of cholera toxin for retroviral antigens delivered by GeneGun.

Authors:  Kenneth C Bagley; George K Lewis; Timothy R Fouts
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

4.  Toll-like receptor-9 induced by physical trauma mediates release of cytokines following exposure to CpG motif in mouse skin.

Authors:  Ling Liu; Xiaohui Zhou; Jianying Shi; Xin Xie; Zhenghong Yuan
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

5.  Human dendritic cells transfected with allergen-DNA stimulate specific immunoglobulin G4 but not specific immunoglobulin E production of autologous B cells from atopic individuals in vitro.

Authors:  Bettina König; Arnd Petersen; Iris Bellinghausen; Ingo Böttcher; Wolf-Meinhard Becker; Jürgen Knop; Joachim Saloga
Journal:  Immunology       Date:  2007-10       Impact factor: 7.397

Review 6.  [Genetic immunization: new ways for protective and therapeutic vaccines against allergic diseases].

Authors:  Sandra Scheiblhofer; Richard Weiss; Josef Thalhamer
Journal:  Wien Med Wochenschr       Date:  2007
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.